Status:
COMPLETED
A Study of RO6799477 in Healthy Volunteers
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Healthy Volunteer
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
This single-center, randomized, double-blind, placebo-controlled, single dose study will investigate the safety, pharmacokinetics, pharmacodynamics of RO6799477 in healthy volunteers.
Eligibility Criteria
Inclusion
- Male healthy volunteers, aged 18-45 years, inclusive
- Male volunteers with female partner of childbearing potential must agree to use an effective form of birth control during the study and for 3 months after discontinuation of treatment.
- Body Mass index (BMI) of 18-30 kg/m2, inclusive
Exclusion
- Infection with human immunodeficiency virus antibody (HIV 1 and 2), Hepatitis B, hepatitis C
- Positive testing for drugs of abuse
- Any history of alcohol and/or drug of abuse addiction
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT01893437
Start Date
July 1 2013
End Date
October 1 2013
Last Update
November 2 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leiden, Netherlands, 2333